Omnia M. Hendawy

Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity

Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy et al. · Bioorganic Chemistry · 2021 · 69 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities

Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea et al. · Bioorganic Chemistry · 2022 · 59 citations

Pharmacy, Medicinal Chemistry, Oncology +16

Influence of Stabilizer on the Development of Luteolin Nanosuspension for Cutaneous Delivery: An In Vitro and In Vivo Evaluation

Mohammed Elmowafy, Khaled Shalaby, Mohammad M. Al‐Sanea et al. · Pharmaceutics · 2021 · 58 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects

Omnia M. Hendawy, Hesham A. M. Gomaa, Sami I. Alzarea et al. · Bioorganic Chemistry · 2021 · 31 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Development of Olive Oil Containing Phytosomal Nanocomplex for Improving Skin Delivery of Quercetin: Formulation Design Optimization, In Vitro and Ex Vivo Appraisals

Omnia M. Hendawy, Mohammad M. Al‐Sanea, Rehab Mohammed Elbargisy et al. · Pharmaceutics · 2023 · 26 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17